Yi Luo
About Yi Luo
Yi Luo is the Clinical Biomarker Lead at Bristol-Myers Squibb in Princeton, with extensive experience in clinical biomarker research for cardiovascular, metabolic, and fibrotic diseases.
Title
Yi Luo is currently the Clinical Biomarker Lead at Bristol-Myers Squibb in Princeton.
Company
Yi Luo works at Bristol-Myers Squibb, a global biopharmaceutical company known for its innovative medicine and research in oncology, immunology, cardiovascular, and fibrotic diseases. Yi Luo has been part of the company since July 2012.
Education and Expertise
Yi Luo holds a Bachelor's degree in Biology from Beijing Normal University and a PhD from the Icahn School of Medicine at Mount Sinai. Luo has expertise in clinical and translational research, focusing primarily on cardiovascular, metabolic, and fibrotic diseases, as well as immune diseases.
Background
Yi Luo's background includes significant experiences in academia and industry. After completing a postdoctoral fellowship at Columbia University from 1997 to 2001, Luo worked as a Senior Scientist at Pharmacia from 2001 to 2003, followed by a 9-year tenure at Pfizer as a Senior Principal Scientist. Since 2012, Luo has been contributing to Bristol-Myers Squibb's clinical biomarker research.
Achievements
Yi Luo has over a decade of experience in clinical biomarker research, particularly for cardiovascular, metabolic, and fibrotic diseases. Luo has played a pivotal role in advancing clinical and translational research during their tenure at Bristol-Myers Squibb and other previous positions.